Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol
about
Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sexAbuse potential of carbohydrates for overweight carbohydrate craversEvaluation of prescription opioids using operant-based pain measures in rats.The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteersPhysical dependence potential of daily tramadol dosing in humans.Principles of laboratory assessment of drug abuse liability and implications for clinical development.Discriminative stimulus effects of tramadol in humans.Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatmentPolydrug abuse: a review of opioid and benzodiazepine combination useFactors related to seizure in tramadol poisoning and its blood concentration.Abuse liability and reinforcing efficacy of oral tramadol in humans.Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users.Worldwide research productivity on tramadol: a bibliometric analysis.The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.Tramadol use in premature ejaculation: daily versus sporadic treatmentThe prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers.Tapentadol immediate release for the relief of moderate-to-severe acute pain.Tapentadol immediate-release for acute pain.Tapentadol extended-release for treatment of chronic pain: a review.Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.The role of tramadol in current treatment strategies for musculoskeletal pain.The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research.Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability.Treatment of Neurogenic Cough with Tramadol: A Pilot Study.Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice.A randomized, double-blind, placebo-controlled, crossover trial of "on-demand" tramadol for treatment of premature ejaculation.Tramadol abuse in a binge pattern in a young depressed woman.Correlates of nonmedical use of hydromorphone and hydrocodone:results from a national household survey.Tramadol: a valuable treatment for pain in Southeast Asian countries
P2860
Q33653525-DE9469F4-D7A9-4305-802F-F8AC52952E8DQ33691741-31025267-4304-493F-9BB7-C3490A3DE50DQ33821443-7C626C40-5A7A-4D3E-AC7B-3E87AC4B9AE7Q33889324-F9DEE652-B2D3-41B2-9F5B-7BB713213B98Q34120202-D65514F8-1C42-4156-BAE3-BF709948E2E5Q34527297-34170F10-1817-47A4-95A2-63FCA1E4C206Q34981070-EC3D3ABB-782E-495C-9BD1-4D7382DFECDDQ35077896-CB358692-5A01-4464-B5DC-49C4612F7154Q36227574-265EC2F9-6F80-4219-B265-550A50500413Q36266246-3E356AEB-3C84-4061-BA98-97BE70315CD4Q36548909-22F9CCCE-6E99-43FB-BD1E-85C546DA8C7FQ36674756-17990AA2-2D3F-4FA6-9BC9-232C65D85FC8Q36930408-30E8B217-8C2E-41AB-B51B-6B903BA35EAEQ37104431-ECB2BEB2-4326-4D76-A526-AE778CD9D5C0Q37156564-F136ED07-447E-41D5-A2D5-0B55CBC6E471Q37204912-268DFBFA-3C16-4A9E-B7F3-1DC1C0D885F0Q37290179-48CC32ED-79F6-4839-A0E8-CC6A1E301EDBQ37366793-1FD83750-61A3-4259-BE77-2B25F608E295Q37606489-776B0893-E120-4F06-B55B-DCC39BC16158Q37762253-ED01638F-6080-4608-986D-7E6701BA3551Q37925605-AC98CEB3-7248-47DB-B1F9-1C1554CB7615Q38120828-B71C7A60-8803-4A83-A898-FF8BDED5333EQ38288633-EE5B55FF-BAD8-4AAF-A93D-939741F65FEEQ38379235-A8EAC091-E230-44E0-A171-8327DD9BB397Q38427278-A4353BE2-9CF3-483C-AFB3-A20AA351C210Q38809172-EC589AFD-5CC0-43BF-86EB-75F6BCB5AB1CQ40814975-6D867D6B-73E0-4716-9EBE-40BABDD343CCQ42693230-5D35D4ED-E286-4A81-BBDB-D29324F8D80BQ44474216-149E36EB-E8E4-4296-9F9B-61FBF11194F9Q46886719-69FA43F3-1F74-49AD-A6FE-66689000D069Q58694485-3BCCA7A4-78E0-46AC-9F1C-A86BF847FE59
P2860
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@ast
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@en
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@nl
type
label
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@ast
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@en
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@nl
prefLabel
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@ast
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@en
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@nl
P2860
P3181
P1476
Abuse liability, behavioral ph ...... animals: lessons from tramadol
@en
P2093
David H Epstein
Donald R Jasinski
P2860
P3181
P356
10.1016/J.BIOPSYCHO.2006.01.010
P407
P577
2006-02-23T00:00:00Z